Abstract
Background: Pregnant women can be considered a sentinel population, because they are a relatively unselected population whose prevalence data may be extended to the general population. Methods: A seroepidemiological study was carried out in Padua (North-East Italy) to assess the epidemiological aspects of HCV, HBV and HIV infection in 2059 pregnant women consecutively seen at the Department of Obstetrics and Gynaecology during 1996. Out of them, 1804 (87.2%) were indigenous and 255 (12.8%) immigrants. Sociodemographical and sanitary data were collected for each woman. Results: The overall prevalence of anti-HCV was 1.9% (42.5% with detectable HCV-RNA); HBsAg was found in 1.0%; the prevalence of anti-HIV was 0.3%. Findings are substantially consistent with the epidemiological picture of such infections in the general population of our geographic area. A parenteral risk factor for HCV infection was found in 19 subjects (47.5%): 18 were intravenous drug users and 1 a blood transfusion recipient. HBsAg seroprevalence was higher in immigrants than in autochthonous (3.1% vs. 0.7% respectively, p < 0.01). One of the 6 anti-HIV positive women was intravenous drug user. Logistic regression analysis was carried out for each viral agent to determine which characteristics were independently associated with infection: anti-HCV prevalence resulted independently associated to Italian origin (OR: 3.7), unmarried status (OR: 2.7), unemployed condition (OR: 6.1) and history of previous abortion (OR: 2.8). HBsAg prevalence was independently associated to unemployed condition (OR: 10.8), whereas HIV positivity was significantly related to the unmarried status (OR: 18.5). Conclusion: Our study pinpoints the need of screening all pregnant women for HCV and HIV infection, in addition to the HBsAg screening which is compulsory in Italy.
Similar content being viewed by others
References
Hoff R, Berardi VP, Weiblen BJ, et al. Seroprevalence of human immunodeficiency virus among childbearing women. N Engl J Med 1988; 318: 525–530.
Dondero TJ, Curran JW. Serosurveillance of human immunodeficiency virus infection. Am J Public Health 1991; 81: 561–562.
Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of Northern Italy: The Dionysos Study. Hepatology 1994; 20: 1442–1449.
Stroffolini T, Menchinelli M, Taliani G. High prevalence of hepatitis C virus infection in a small central Italian town: Lack of evidence of parenteral exposure. Ital J Gastroenterol 1995; 27: 235–238.
Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in Southern Italy. Hepatology 1997; 26: 1006–1011.
Mele A, Stroffolini T, Pasquini P. SEIEVA. Integrated Epidemiological System for Acute Viral Hepatitis in Italy. Report 1985–1994. Rapporti ISTISAN 96/3 1996; 7: 1–33.
Mele A, Marzolini A, Tosti ME, et al. SEIEVA. Integrated Epidemiological System for Acute Viral Hepatitis. Report 1995–1996. Rome (Italy): Rapporti ISTISAN 97/36 1997; 8: 1–57 [in Italian].
Stroffolini T, Pasquini P, Mele A. HBsAg carriers among pregnant women in Italy. Public Health 1988; 102: 329–333.
CDC. US Public Health Service Recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR 1995; 44 (No. RR-7): 1–15.
Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995; 345: 289–291.
Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 1997; 9: 3–33.
Chiaramonte M, Stroffolini T, Lorenzoni U, et al. Risk factors in community-acquired chronic hepatitis C virus infection: Case-control study in Italy. J Hepatol 1996; 24: 129–134.
Crovari P. Epidemiology of viral hepatitis B in Italy. Vaccine 1995; 13 (S1): 26–30.
Istituto Superiore di Sanità. Aggiornamento dei casi di AIDS notificati in Italia al 30 giugno 1997. Notiziario Istituto Superiore di Sanità 1997; 10 (S1): 1–12 [in Italian].
CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47 (No. RR-19): 1–39.
Marranconi F, Fabris P, Stecca C, et al. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 1994; 22: 333–337.
Margolis HS, Alter MJ, Hadler SC. Hepatitis B: Evolving epidemiology and implications for control. Sem Liv Dis 1991; 11: 84–92.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baldo, V., Floreani, A., Menegon, T. et al. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: A seroepidemiological study. Eur J Epidemiol 16, 87–91 (2000). https://doi.org/10.1023/A:1007600532105
Issue Date:
DOI: https://doi.org/10.1023/A:1007600532105